Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q1 FY21 results · Apr–Jun 2020
Divi's Laboratories reported revenue from operations of ₹1,730.47 crore (up 48.8% from Q1 FY20) and net profit of ₹492.06 crore (up 80.6% from Q1 FY20) for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,730.47 | 1,162.88 | +48.8% | 1,389.71 | +24.5% |
| Other income | 17.33 | 30.32 | −42.8% | 76.73 | −77.4% |
| Total income | 1,747.80 | 1,193.20 | +46.5% | 1,466.44 | +19.2% |
| Profit before tax | 660.98 | 373.31 | +77.1% | 470.96 | +40.3% |
| Net profit for the period | 492.06 | 272.44 | +80.6% | 388.23 | +26.7% |
| EPS, basic (₹) | 18.54 | 10.26 | +80.7% | 14.62 | +26.8% |
| Net margin (%) | 28.4 | 23.4 | 27.9 |
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,709.96 | 1,139.92 | +50.0% | 1,376.24 | +24.2% |
| Other income | 17.87 | 31.63 | −43.5% | 76.52 | −76.6% |
| Total income | 1,727.83 | 1,171.55 | +47.5% | 1,452.76 | +18.9% |
| Profit before tax | 660.70 | 366.11 | +80.5% | 475.22 | +39.0% |
| Net profit for the period | 492.25 | 267.35 | +84.1% | 391.80 | +25.6% |
| EPS, basic (₹) | 18.54 | 10.07 | +84.1% | 14.76 | +25.6% |
| Net margin (%) | 28.8 | 23.5 | 28.5 |
Consolidated
- Filed with BSE
- 08 Aug 2020, 14:33 IST
- Board meeting
- 08 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Aug 2020, 14:33 IST
- Board meeting
- 08 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE